CytoDyn Inc. Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	May 31, 2024	May 31, 2023
Summary of Significant Accounting Policies
Federal statutory income tax rate, percent	21.00%	21.00%
Income tax expense	$ 0	$ 0

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.